Fluent Inc Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Uncertainty KALV Q1 2026 Earnings Narrower Loss Beats Expectations Clinical Pipeline Progress Underway RenovoRx Q1 2026 Earnings EPS Miss as PreRevenue Biotech Continues Clinical Development DLR Q1 2026 Earnings Slight EPS Beat Amid Data Center Demand Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings Wider Than Expected Loss Highlights PreRevenue Challenges Bank of Marin Bancorp BMRC Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Landscape